Epigenetic and Transcriptional Regulation of Innate Immunity in Cancer
暂无分享,去创建一个
S. Nimer | F. Liu | N. Man | H. Itonaga | Jun Sun | Chuan Chen | Gloria Mas Martin
[1] C. Ishioka,et al. Inhibition of IRAK1/4 enhances the antitumor effect of lenvatinib in anaplastic thyroid cancer cells , 2021, Cancer science.
[2] A. Marciscano,et al. The role of dendritic cells in cancer and anti-tumor immunity. , 2021, Seminars in immunology.
[3] M. Karin,et al. Targeting cancer-promoting inflammation — have anti-inflammatory therapies come of age? , 2021, Nature Reviews Clinical Oncology.
[4] Shengqi Wang,et al. Research trends in pharmacological modulation of tumor‐associated macrophages , 2021, Clinical and translational medicine.
[5] S. Cuzzocrea,et al. TAK1 Inhibitor Enhances the Therapeutic Treatment for Glioblastoma , 2020, Cancers.
[6] Jin-jian Lu,et al. The development of small-molecule inhibitors targeting CD47. , 2020, Drug discovery today.
[7] U. Kishore,et al. Interplay between C‐type lectin receptors and microRNAs in cellular homeostasis and immune response , 2020, The FEBS journal.
[8] Joseph Cursons,et al. The cancer–natural killer cell immunity cycle , 2020, Nature Reviews Cancer.
[9] Caicun Zhou,et al. cGAS-STING, an important pathway in cancer immunotherapy , 2020, Journal of Hematology & Oncology.
[10] M. Ratajczak,et al. The Nlrp3 inflammasome as a “rising star” in studies of normal and malignant hematopoiesis , 2020, Leukemia.
[11] Minghua Deng,et al. IL-4 Alleviates Ischaemia-Reperfusion Injury by Inducing Kupffer Cells M2 Polarization via STAT6-JMJD3 Pathway after Rat Liver Transplantation , 2020, BioMed research international.
[12] J. Rehwinkel,et al. RIG-I-like receptors: their regulation and roles in RNA sensing , 2020, Nature Reviews Immunology.
[13] R. Xavier,et al. Defining trained immunity and its role in health and disease , 2020, Nature Reviews Immunology.
[14] K. Leandersson,et al. The Generation and Identity of Human Myeloid-Derived Suppressor Cells , 2020, Frontiers in Oncology.
[15] Juan Chen,et al. DNA methylation is involved in the pathogenesis of osteoarthritis by regulating CtBP expression and CtBP-mediated signaling , 2020, International journal of biological sciences.
[16] E. Ballestar,et al. SIRT1/2 orchestrate acquisition of DNA methylation and loss of histone H3 activating marks to prevent premature activation of inflammatory genes in macrophages , 2019, Nucleic acids research.
[17] M. Shaul,et al. Tumour-associated neutrophils in patients with cancer , 2019, Nature Reviews Clinical Oncology.
[18] A. Wang,et al. Overcoming adaptive therapy resistance in AML by targeting immune response pathways , 2019, Science Translational Medicine.
[19] D. Muruve,et al. NOD-like receptors and inflammasomes: A review of their canonical and non-canonical signaling pathways. , 2019, Archives of biochemistry and biophysics.
[20] L. Folkersen,et al. KLF12 Regulates Mouse NK Cell Proliferation , 2019, The Journal of Immunology.
[21] D. Pagliarini,et al. Two-stage metabolic remodelling in macrophages in response to lipopolysaccharide and interferon-γ stimulation , 2019, Nature Metabolism.
[22] L. Joosten,et al. Therapeutic targeting of trained immunity , 2019, Nature Reviews Drug Discovery.
[23] Dov A. Pechenick,et al. Hypoxia-Induced VISTA Promotes the Suppressive Function of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment , 2019, Cancer Immunology Research.
[24] J. Ting,et al. The NLRP3 inflammasome: molecular activation and regulation to therapeutics , 2019, Nature Reviews Immunology.
[25] M. Gustafsson,et al. Identification of DNA methylation patterns predisposing for an efficient response to BCG vaccination in healthy BCG-naïve subjects , 2019, Epigenetics.
[26] L. Kandalaft,et al. Personalized Dendritic Cell Vaccines—Recent Breakthroughs and Encouraging Clinical Results , 2019, Front. Immunol..
[27] G. Lenz,et al. Safeguard function of PU.1 shapes the inflammatory epigenome of neutrophils , 2019, Nature Immunology.
[28] A. Blom,et al. Mature neutrophils suppress T cell immunity in ovarian cancer microenvironment. , 2019, JCI insight.
[29] Philipp S. Hoppe,et al. Inflammatory signals directly instruct PU.1 in HSCs via TNF. , 2019, Blood.
[30] T. Mogensen. IRF and STAT Transcription Factors - From Basic Biology to Roles in Infection, Protective Immunity, and Primary Immunodeficiencies , 2019, Front. Immunol..
[31] John G Doench,et al. Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade , 2018, Nature.
[32] Shiping Liao,et al. NG25, a novel inhibitor of TAK1, suppresses KRAS-mutant colorectal cancer growth in vitro and in vivo , 2018, Apoptosis.
[33] É. Vivier,et al. Natural killer cells and other innate lymphoid cells in cancer , 2018, Nature Reviews Immunology.
[34] C. Franceschi,et al. Inflammaging: a new immune–metabolic viewpoint for age-related diseases , 2018, Nature Reviews Endocrinology.
[35] M. Ingersoll,et al. Mechanisms of BCG immunotherapy and its outlook for bladder cancer , 2018, Nature Reviews Urology.
[36] Joseph C. Sun,et al. Transcription Factor IRF8 Orchestrates the Adaptive Natural Killer Cell Response , 2018, Immunity.
[37] M. Nahrendorf. Myeloid cell contributions to cardiovascular health and disease , 2018, Nature Medicine.
[38] S. Landolfo,et al. The Absent in Melanoma 2-Like Receptor IFN-Inducible Protein 16 as an Inflammasome Regulator in Systemic Lupus Erythematosus: The Dark Side of Sensing Microbes , 2018, Front. Immunol..
[39] K. Błaszczyk,et al. A Positive Feedback Amplifier Circuit That Regulates Interferon (IFN)-Stimulated Gene Expression and Controls Type I and Type II IFN Responses , 2018, Front. Immunol..
[40] J. Lang,et al. TAK1 mediates microenvironment-triggered autocrine signals and promotes triple-negative breast cancer lung metastasis , 2018, Nature Communications.
[41] I. Ng,et al. IRAK1 Augments Cancer Stemness and Drug Resistance via the AP-1/AKR1B10 Signaling Cascade in Hepatocellular Carcinoma. , 2018, Cancer research.
[42] B. Ye,et al. A Circular RNA Protects Dormant Hematopoietic Stem Cells from DNA Sensor cGAS‐Mediated Exhaustion , 2018, Immunity.
[43] H. Kuo,et al. Epigenetic hypomethylation and upregulation of NLRC4 and NLRP12 in Kawasaki disease , 2018, Oncotarget.
[44] Gordon D. Brown,et al. C-type lectins in immunity and homeostasis , 2018, Nature Reviews Immunology.
[45] O. Pikovskaya,et al. Cutting Edge: Divergent Requirement of T-Box Transcription Factors in Effector and Memory NK Cells , 2018, The Journal of Immunology.
[46] Irah L. King,et al. BCG Educates Hematopoietic Stem Cells to Generate Protective Innate Immunity against Tuberculosis , 2018, Cell.
[47] M. Oosting,et al. Western Diet Triggers NLRP3-Dependent Innate Immune Reprogramming , 2018, Cell.
[48] R. Horst,et al. Metabolic Induction of Trained Immunity through the Mevalonate Pathway , 2018, Cell.
[49] L. Joosten,et al. Modulation of Myelopoiesis Progenitors Is an Integral Component of Trained Immunity , 2018, Cell.
[50] Joseph C. Sun,et al. Core-binding factor β and Runx transcription factors promote adaptive natural killer cell responses , 2017, Science Immunology.
[51] A. Mortazavi,et al. Prostaglandin E2 Leads to the Acquisition of DNMT3A-Dependent Tolerogenic Functions in Human Myeloid-Derived Suppressor Cells. , 2017, Cell reports.
[52] Mihaela M. Martis,et al. Anti-mycobacterial activity correlates with altered DNA methylation pattern in immune cells from BCG-vaccinated subjects , 2017, Scientific Reports.
[53] E. Tagliabue,et al. Exploiting poly(I:C) to induce cancer cell apoptosis , 2017, Cancer biology & therapy.
[54] John G. Doench,et al. In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target , 2017, Nature.
[55] Chih-Hung Chou,et al. α-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming , 2017, Nature Immunology.
[56] L. Cascione,et al. Preclinical evaluation of the BET bromodomain inhibitor BAY 1238097 for the treatment of lymphoma , 2017, British journal of haematology.
[57] S. Gabriel,et al. Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease , 2017, The New England journal of medicine.
[58] V. Beneš,et al. Vitamin A-Retinoic Acid Signaling Regulates Hematopoietic Stem Cell Dormancy , 2017, Cell.
[59] Austin Miller,et al. The Granulocyte Progenitor Stage Is a Key Target of IRF8-Mediated Regulation of Myeloid-Derived Suppressor Cell Production , 2017, The Journal of Immunology.
[60] Matthew A. Cooper,et al. Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice , 2017, Science.
[61] Si Ming Man,et al. Inflammasomes and Cancer , 2017, Cancer Immunology Research.
[62] K. Leandersson,et al. On the origin of myeloid-derived suppressor cells , 2016, Oncotarget.
[63] E. Bruscia,et al. Cellular Innate Immunity: An Old Game with New Players , 2016, Journal of Innate Immunity.
[64] Richard A. Notebaart,et al. Glutaminolysis and Fumarate Accumulation Integrate Immunometabolic and Epigenetic Programs in Trained Immunity. , 2016, Cell metabolism.
[65] M. Kimmel,et al. Chronic Infection Depletes Hematopoietic Stem Cells through Stress-Induced Terminal Differentiation. , 2016, Cell reports.
[66] M. Oosting,et al. Immunometabolic Pathways in BCG-Induced Trained Immunity , 2016, Cell reports.
[67] M. Netea,et al. Innate immune cell activation in symptomatic and asymptomatic atherosclerosis in humans in vivo , 2016 .
[68] N. Senzer,et al. A Phase II Efficacy and Safety, Open-Label, Multicenter Study of Imprime PGG Injection in Combination With Cetuximab in Patients With Stage IV KRAS-Mutant Colorectal Cancer. , 2016, Clinical colorectal cancer.
[69] A. Cardoso,et al. Sepsis Induces Hematopoietic Stem Cell Exhaustion and Myelosuppression through Distinct Contributions of TRIF and MYD88 , 2016, Stem cell reports.
[70] R. Xavier,et al. Trained immunity: A program of innate immune memory in health and disease , 2016, Science.
[71] Y. Saeys,et al. Yolk Sac Macrophages, Fetal Liver, and Adult Monocytes Can Colonize an Empty Niche and Develop into Functional Tissue-Resident Macrophages. , 2016, Immunity.
[72] T. Assimes,et al. The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease , 2016, The Journal of experimental medicine.
[73] S. Nakae,et al. Promotion of Expansion and Differentiation of Hematopoietic Stem Cells by Interleukin-27 into Myeloid Progenitors to Control Infection in Emergency Myelopoiesis , 2016, PLoS pathogens.
[74] Joseph C. Sun,et al. Type I IFN promotes NK cell expansion during viral infection by protecting NK cells against fratricide , 2016, The Journal of experimental medicine.
[75] L. Lenz,et al. A Breakthrough: Macrophage-Directed Cancer Immunotherapy. , 2016, Cancer research.
[76] C. Glass,et al. Molecular control of activation and priming in macrophages , 2015, Nature Immunology.
[77] S. Orkin,et al. Ezh2 regulates differentiation and function of natural killer cells through histone methyltransferase activity , 2015, Proceedings of the National Academy of Sciences.
[78] Inhwa Hwang,et al. Histone deacetylase 6 negatively regulates NLRP3 inflammasome activation. , 2015, Biochemical and biophysical research communications.
[79] M. Beckmann,et al. Abstract B32: Inhibiting DNA methylation causes an interferon response in cancer via dsRNA including endogenous retroviruses , 2016 .
[80] D. Starczynowski,et al. Deconstructing innate immune signaling in myelodysplastic syndromes. , 2015, Experimental hematology.
[81] Si Ming Man,et al. Regulation of inflammasome activation , 2015, Immunological reviews.
[82] Sky W. Brubaker,et al. Innate immune pattern recognition: a cell biological perspective. , 2015, Annual review of immunology.
[83] R. Weissleder,et al. Interleukin-3 amplifies acute inflammation and is a potential therapeutic target in sepsis , 2015, Science.
[84] P. Coffer,et al. Acetylation of C/EBPε is a prerequisite for terminal neutrophil differentiation. , 2015, Blood.
[85] P. Ricciardi-Castagnoli,et al. NFATc2 mediates epigenetic modification of dendritic cell cytokine and chemokine responses to dectin-1 stimulation , 2014, Nucleic acids research.
[86] Ronit Vogt Sionov,et al. The Multifaceted Roles Neutrophils Play in the Tumor Microenvironment , 2015, Cancer Microenvironment.
[87] M. McCarthy,et al. Age-related clonal hematopoiesis associated with adverse outcomes. , 2014, The New England journal of medicine.
[88] L. Kiemeney,et al. Autophagy Controls BCG-Induced Trained Immunity and the Response to Intravesical BCG Therapy for Bladder Cancer , 2014, PLoS pathogens.
[89] R. Xavier,et al. Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity , 2014, Science.
[90] R. Xavier,et al. mTOR- and HIF-1α–mediated aerobic glycolysis as metabolic basis for trained immunity , 2014, Science.
[91] R. Aoki,et al. Innate and intrinsic antiviral immunity in skin. , 2014, Journal of dermatological science.
[92] E. Davila,et al. IL-1 Receptor-Associated Kinase Signaling and Its Role in Inflammation, Cancer Progression, and Therapy Resistance , 2014, Front. Immunol..
[93] S. Goerdt,et al. Macrophage activation and polarization: nomenclature and experimental guidelines. , 2014, Immunity.
[94] Vishva M. Dixit,et al. Mechanisms and Functions of Inflammasomes , 2014, Cell.
[95] Q. Tu,et al. BET Inhibitor JQ1 Blocks Inflammation and Bone Destruction , 2014, Journal of dental research.
[96] Ryan M. O’Connell,et al. Conversion of danger signals into cytokine signals by hematopoietic stem and progenitor cells for regulation of stress-induced hematopoiesis. , 2014, Cell stem cell.
[97] D. Link,et al. G-CSF regulates hematopoietic stem cell activity, in part, through activation of toll-like receptor signaling , 2014, Leukemia.
[98] P. De Baetselier,et al. Tumor‐induced myeloid‐derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T‐cell activation events , 2013, European journal of immunology.
[99] D. Neuberg,et al. Toll-like receptor alterations in myelodysplastic syndrome , 2013, Leukemia.
[100] Thomas A. Wynn,et al. Macrophage biology in development, homeostasis and disease , 2013, Nature.
[101] J. Tschopp,et al. NLRP3 suppresses NK cell-mediated responses to carcinogen-induced tumors and metastases. , 2012, Cancer research.
[102] R. Xavier,et al. Bacille Calmette-Guérin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes , 2012, Proceedings of the National Academy of Sciences.
[103] S. Bultman,et al. Metaboloepigenetics: Interrelationships between energy metabolism and epigenetic control of gene expression , 2012, Journal of cellular physiology.
[104] S. Albelda,et al. Tumor-associated neutrophils: friend or foe? , 2012, Carcinogenesis.
[105] Alberto Mantovani,et al. Macrophage plasticity and polarization: in vivo veritas. , 2012, The Journal of clinical investigation.
[106] H. Du,et al. Inhibition of PPARγ in myeloid-lineage cells induces systemic inflammation, immunosuppression, and tumorigenesis. , 2012, Blood.
[107] M. Netea,et al. Trained immunity: a memory for innate host defense. , 2011, Cell host & microbe.
[108] J. Serody,et al. The inflammasome component NLRP3 impairs antitumor vaccine by enhancing the accumulation of tumor-associated myeloid-derived suppressor cells. , 2010, Cancer research.
[109] K. Nakai,et al. The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection , 2010, Nature Immunology.
[110] K. Garrett,et al. Functional diversity of stem and progenitor cells with B‐lymphopoietic potential , 2010, Immunological reviews.
[111] Nathan C Boles,et al. Quiescent hematopoietic stem cells are activated by IFNγ in response to chronic infection , 2010, Nature.
[112] S. Weiss,et al. Neutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor model. , 2010, The Journal of clinical investigation.
[113] S. Akira,et al. Pattern Recognition Receptors and Inflammation , 2010, Cell.
[114] M. Sieweke,et al. MafB/c-Maf Deficiency Enables Self-Renewal of Differentiated Functional Macrophages , 2009, Science.
[115] L. Rahme,et al. Dysfunctional expansion of hematopoietic stem cells and block of myeloid differentiation in lethal sepsis. , 2009, Blood.
[116] Y. Dou,et al. Epigenetic regulation of the alternatively activated macrophage phenotype. , 2009, Blood.
[117] G. Cheng,et al. Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN. , 2009, Cancer cell.
[118] J. Edwards,et al. Exploring the full spectrum of macrophage activation , 2008, Nature Reviews Immunology.
[119] David A. Hume,et al. Macrophages as APC and the Dendritic Cell Myth , 2008, The Journal of Immunology.
[120] W. Nacken,et al. Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein , 2008, The Journal of experimental medicine.
[121] M. Colombo,et al. The terminology issue for myeloid-derived suppressor cells. , 2007, Cancer research.
[122] S. Akira,et al. Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment. , 2006, Immunity.
[123] J. Gready,et al. The C‐type lectin‐like domain superfamily , 2005, The FEBS journal.
[124] S. Sriskandan,et al. Mammalian Toll‐like receptors: to immunity and beyond , 2005, Clinical and experimental immunology.
[125] J. Lustgarten,et al. Flagellin Fusion Proteins as Adjuvants or Vaccines Induce Specific Immune Responses , 2004, Infection and Immunity.
[126] E. Wagner,et al. AP-1: a double-edged sword in tumorigenesis , 2003, Nature Reviews Cancer.
[127] H. Gollnick,et al. Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod. , 2003, Journal of the National Cancer Institute.
[128] M. Chamaillard,et al. Nod2 Is a General Sensor of Peptidoglycan through Muramyl Dipeptide (MDP) Detection* , 2003, The Journal of Biological Chemistry.
[129] J. Darnell,et al. Signalling: STATs: transcriptional control and biological impact , 2002, Nature Reviews Molecular Cell Biology.
[130] R. Vile. Faculty Opinions recommendation of IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. , 2001 .
[131] S. Akira,et al. A Toll-like receptor recognizes bacterial DNA , 2000, Nature.
[132] E. Pietras,et al. Chronic interleukin-1 drives haematopoietic stem cells towards precocious myeloid differentiation at the expense of self-renewal , 2016, Nature Cell Biology.